Whole-genome high-fidelity sequencing: A novel approach to detecting and characterization of mutagenicity in vivo

Mutat Res Genet Toxicol Environ Mutagen. 2023 Oct:891:503691. doi: 10.1016/j.mrgentox.2023.503691. Epub 2023 Sep 9.

Abstract

Direct DNA sequencing can be used for characterizing mutagenicity in simple and complex biological models. Recently we described a method of whole-genome sequencing for detecting mutations in simple models of cultured bacteria, mammalian cells, and nematode. In the current proof-of-concept study, we expand and improve our method for evaluating a more complex mammalian biological model in outbred mice. We detail the method by applying it to a small set of animals treated with a mutagen with known mutagenicity profiles, N-ethyl-N-nitrosourea (ENU), for consistency with the known data. Whole-genome high-fidelity sequencing (HiFi Sequencing) showed frequencies and spectra of background mutations in tissues of untreated mice that were consistent with normal ageing and characterized by spontaneous or enzymatic deamination of 5-methylcytosine. In mice treated with a single 40 mg/kg dose of ENU, the frequency of mutations in the genomic DNA of solid tissues increased up to 7-fold, with the greatest increase observed in the spleen and the smallest increase in the liver. The most common mutations detected in ENU-treated mice were T > A transitions and T > C transversions, consistent with the types of mutations caused by alkylating agents. The data suggest that HiFi Sequencing may be useful for characterizing mutagenicity of novel compounds in various biological models.

Keywords: Kidney; Liver; Mutational signature; Mutational spectrum; N-ethyl-N-nitrosourea; Spleen.

MeSH terms

  • Alkylating Agents*
  • Animals
  • DNA
  • Ethylnitrosourea / toxicity
  • Mammals
  • Mice
  • Mutagenesis
  • Mutagenicity Tests
  • Mutagens* / toxicity
  • Mutation

Substances

  • Mutagens
  • Alkylating Agents
  • Ethylnitrosourea
  • DNA